The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
about
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou SocDiagnostic accuracy of Ber-EP4 for metastatic adenocarcinoma in serous effusions: a meta-analysis.Diagnostic accuracy of MOC-31 for malignant effusions: a meta-analysis.Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis.Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional ExperienceGene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status.Immunocytochemistry: an indispensable technique in routine cytology.The diagnostic and research applications of flow cytometry in cytopathology.Cell blocks in cytopathology: a review of preparative methods, utility in diagnosis and role in ancillary studies.Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the PapanicolaouGuidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication.MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancerCytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.An update on pleuro-pulmonary cytopathology: Part i: Cytological diagnosis of mesothelioma and molecular cytology of lung cancer with an historical perspective.Should cytology be an acceptable means of diagnosing malignant mesothelioma?Fine needle aspiration cytology of a nodal low-grade serous neoplasm: a case report of low-grade serous carcinoma arising from a serous borderline tumour with cyto-histological correlation.The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: An institutional experienceCytologic examination of ascitic fluid in a patient with pleural-based mass: A unique presentation of a rare tumor
P2860
Q26774926-68DC01B4-1F91-4E4A-9254-0B27B24FD8CBQ34208620-F416BA57-70DC-4E0E-B55A-83FE3CC3A77BQ35115030-3B4ED3BD-6E25-4FC7-B5D6-74C5FE7E9322Q35227255-1DB1A323-E225-4816-B836-9C48746E404BQ35800914-62F9CD39-BD5A-4F05-80BC-2E5BD575E83EQ35837949-F4B09FC7-F308-4521-8ADD-BB84C2488B7BQ36252868-B31EF4C0-4967-44E9-9A2C-CD89CA5B7DBAQ37091852-254F5CD8-9F94-4D1E-B4C8-EE6E011E9411Q37712647-758C2D05-6691-433D-B1D6-23B2F252F03AQ37902694-123560DB-320F-4811-960E-7D3820453E8FQ38012418-93092F67-241D-417A-B407-2642D102F4F8Q38239059-37CEA1AC-DC09-41F8-AC10-57A22BD2376FQ40809939-07AAC63B-6F4D-4646-BF07-D9B8958716B2Q40860144-82F1F272-3562-4C4B-84CA-D65A296B1942Q42102343-E8A9395B-5866-4A3A-8496-59C07366CF0FQ46644119-363FF9EF-A4A4-4D78-8529-16D22ECBEFD6Q48026907-EF278715-B2EC-4E50-B506-63C142F0464AQ51767012-912F1D86-BE79-48A9-9373-E4B439BC00E7Q53758785-9769DBE8-0DB4-4CCF-8DDD-4E2F1F1BDBD0Q57713259-24148FC4-7EE9-465B-B695-3425F2864CA0Q58561912-0C69AE41-F1F5-4F25-A36C-0CA1DC6B8CC9
P2860
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The diagnostic and molecular c ...... n/peritoneal serous carcinoma.
@en
The diagnostic and molecular c ...... n/peritoneal serous carcinoma.
@nl
type
label
The diagnostic and molecular c ...... n/peritoneal serous carcinoma.
@en
The diagnostic and molecular c ...... n/peritoneal serous carcinoma.
@nl
prefLabel
The diagnostic and molecular c ...... n/peritoneal serous carcinoma.
@en
The diagnostic and molecular c ...... n/peritoneal serous carcinoma.
@nl
P2860
P1433
P1476
The diagnostic and molecular c ...... n/peritoneal serous carcinoma.
@en
P2093
B Davidson
P2860
P356
10.1111/J.1365-2303.2010.00829.X
P577
2010-11-30T00:00:00Z